Stockreport

Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March ...

Humacyte, Inc.  (HUMA) 
PDF company developing universally implantable, bioengineered human tissues at commercial scale, today announced it will host an in-person and virtual investor event in New [Read more]